Respiratory Syncytial Virus

Respiratory·MeSH: COVID-19

84 drugs in development·16 companies·10 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
enflonsia	Merck & Co., Inc. (MRK)

Phase 3(23)

Drug	Company
20vpcv licensed vaccine	Sanofi (SNY)
acne mrna vaccine	Sanofi (SNY)
Afluria® Quadrivalent	Moderna, Inc. (MRNA)
AZM Group	INSMED Inc (INSM)
Fluzone HD	Moderna, Inc. (MRNA)
formulation buffer	NOVAVAX INC (NVAX)
nirsevimab	ASTRAZENECA PLC (AZN)
palivizumab	ASTRAZENECA PLC (AZN)
pandemic flu h5 mrna vaccine	Sanofi (SNY)
parainfluenza virus type 3 vaccine	Sanofi (SNYNF)
rsv f vaccine with adjuvant	NOVAVAX INC (NVAX)
rsv vaccine formulation 3 dose	Sanofi (SNY)
rsv vaccine formulation 4 dose	Sanofi (SNY)
rsv vaccine formulation 5 dose	Sanofi (SNY)
rsv vaccine formulation 6 dose	Sanofi (SNY)
rsv vaccine formulation 8 dose	Sanofi (SNY)
rsv/hmpv vaccine	Sanofi (SNYNF)
rsv/hmpv vaccine candidate dose a	Sanofi (SNY)
rsv/hmpv vaccine candidate dose b	Sanofi (SNY)
rsv/hmpv vaccine candidate dose l	Sanofi (SNY)
rsv/hmpv/piv3 vaccine	Sanofi (SNY)
rsvt vaccine	Sanofi (SNY)
sim0916	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 2(10)

Drug	Company
Clesrovimab	Merck & Co., Inc. (MRK)
EDP-938	ENANTA PHARMACEUTICALS INC (ENTA)
High dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
High dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
ivx-121	Icosavax, Inc. (ICVX)
Low dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Low dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Middle dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Middle dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
rsv vaccine candidate	Sanofi (SNY)

Phase 1(36)

Drug	Company
alvr106	Kalaris Therapeutics, Inc. (KLRS)
h5 flu imp 10	Sanofi (SNY)
h5 flu imp 10	Sanofi (SNYNF)
h5 flu imp 11	Sanofi (SNYNF)
h5 flu imp 11	Sanofi (SNY)
h5 flu imp 12	Sanofi (SNY)
h5 flu imp 12	Sanofi (SNYNF)
h5 flu imp 2	Sanofi (SNY)
h5 flu imp 2	Sanofi (SNYNF)
h5 flu imp 3	Sanofi (SNY)
h5 flu imp 3	Sanofi (SNYNF)
h5 flu imp 7	Sanofi (SNYNF)
h5 flu imp 7	Sanofi (SNY)
h5 flu imp 8	Sanofi (SNY)
h5 flu imp 8	Sanofi (SNYNF)
h5 flu imp 9	Sanofi (SNY)
h5 flu imp 9	Sanofi (SNYNF)
h5 flu investigational medical product 1	Sanofi (SNY)
h5 flu investigational medical product 1	Sanofi (SNYNF)
hmpv mrna lnp 1	Sanofi (SNY)
parainfluenza virus type 3 vaccine	Sanofi (SNY)
rsv imp 4	Sanofi (SNYNF)
rsv imp 4	Sanofi (SNY)
rsv imp 5	Sanofi (SNY)
rsv imp 5	Sanofi (SNYNF)
rsv imp 6	Sanofi (SNYNF)
rsv imp 6	Sanofi (SNY)
rsv mrna lnp 1	Sanofi (SNY)
rsv vaccine 1	Sanofi (SNY)
rsv vaccine 2	Sanofi (SNY)
rsv vaccine formulation 1 dose	Sanofi (SNY)
rsv vaccine formulation 2 dose	Sanofi (SNY)
rsv vaccine formulation 7 dose	Sanofi (SNY)
rsv/hmpv mrna lnp 1	Sanofi (SNY)
rsv/hmpv mrna lnp 2	Sanofi (SNY)
rsv/hmpv vaccine	Sanofi (SNY)

Preclinical(3)

Drug	Company
AR-201	Aridis Pharmaceuticals, Inc. (ARDS)
gv2311	GENVEC INC (GNVC)
rsv vaccine	MYMETICS CORP (MYMX)

Unknown(1)

Drug	Company
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)

Phase 1/Phase 2(2)

Drug	Company
rsv vaccine formulation 1	Sanofi (SNY)
rsv vaccine formulation 2	Sanofi (SNY)

Phase 4(8)

Drug	Company
High dose potent statin	Cidara Therapeutics, Inc. (CDTX)
mRNA-1273.214	Moderna, Inc. (MRNA)
mRNA-1345	Moderna, Inc. (MRNA)
nirsevimab	Sanofi (SNY)
nirsevimab respiratory syncytial virus monoclonal antibody	Sanofi (SNY)
Postoperative pain management with acetaminophen	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with dexketoprofen	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with metamizole	Cidara Therapeutics, Inc. (CDTX)

BioSniper tracks 84 drugs in development for Respiratory Syncytial Virus across 16 companies.

There are 10 clinical trials targeting Respiratory Syncytial Virus tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.